Carl Walsh

Carl Walsh

patient unknown

Carl Walsh, a 59-year-old from Birmingham, has been participating in a clinical trial for a new cancer treatment after traditional therapies failed to manage his tongue cancer. Since beginning the trial in July, he has experienced significant improvements in his condition, including reduced swelling and pain, allowing him to regain some normalcy in his daily life.

Born on May 01, 1968 (58 years old)

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned

No country-level mention data available.

Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Vietnam Vietnam: Carl Walsh, diagnosed with tongue cancer, participated in the amivantamab clinical trial and has shown significant recovery. 9

VnExpress – leading Vietnamese online newspaper, est. 2001: Thuốc tiêm mới có thể xóa sổ khối u ung thư giai đoạn cuối

Romania Romania: Carl Walsh, diagnosed with tongue cancer, was one of the first patients to benefit from the treatment. 9

Adevărul: Tratament împotriva cancerului cu rezultate fără precedent: injecția care poate elimina complet tumorile

Ireland Ireland: Carl Walsh, diagnosed with tongue cancer, shared his positive experience with the OrigAMI-4 trial treatment. 9

The Irish Times – major Irish daily, est. 1859: Cancer jab can eradicate entire tumours in patients, trial shows – The Irish Times

United Kingdom United Kingdom: Carl Walsh, diagnosed with tongue cancer, expressed his satisfaction with the progress of his treatment in the OrigAMI-4 trial. 9

The Guardian: Cancer jab can eradicate entire tumours in patients, trial shows | Cancer research

Brazil Brazil: Carl Walsh, a 59-year-old resident of Birmingham, shares how the treatment has improved his quality of life after being diagnosed with tongue cancer. 9

O Globo: ‘Injeção inteligente’ mostra promessa no tratamento de câncer avançado de cabeça e pescoço

United Kingdom United Kingdom: Carl Walsh, a patient with tongue cancer, shared his positive experience with the trial treatment amivantamab. 9

The Guardian: Smart jab can shrink head and neck cancer tumours within six weeks, trial finds | Cancer research